Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Sanofi
Related studies linked through entity extraction aliases.
Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Long-term Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With Venglustat
- Status
- TERMINATED
- Phase
- PHASE3
Effect of Dronedarone on Atrial Fibrosis Progression and Atrial Fibrillation Recurrence
- Status
- TERMINATED
- Phase
- PHASE4
Ultra Curto (Ultra Short) TB Prevention Therapy
- Status
- COMPLETED
- Phase
- PHASE4
Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI)
- Status
- COMPLETED
- Phase
- PHASE3
Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)
- Status
- COMPLETED
- Phase
- PHASE3
Anti-PD1-antibody and Pulsed HHI for Advanced BCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Dupilumab in Japanese Patients With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Dupilumab in CRSsNP
- Status
- COMPLETED
- Phase
- PHASE2
My Dose Coach Mobile App to Support Insulin Titration and Maintenance
- Status
- TERMINATED
- Phase
- NA
A Study to Evaluate the Efficacy and the Safety of Single Pill Combination (SPC) Ezetimibe/Rosuvastatin in Chinese Adult Patients With Primary Hypercholesterolemia Not Adequately Controlled on Statin Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Sarilumab Treatment In cytoKinE Storm Caused by Infection With COVID-19
- Status
- UNKNOWN
- Phase
- PHASE2
Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia (wAIHA)
- Status
- TERMINATED
- Phase
- PHASE2
Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
French National Cohort of People With Type 1 Diabetes
- Status
- RECRUITING
- Phase
- N/A
Study to Evaluate Efficacy and Safety of Imiglucerase Treatment in Chinese Patients With Gaucher Disease Type Ⅲ
- Status
- COMPLETED
- Phase
- PHASE4
Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone in NDMM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Isatuximab in Combination With Novel Agents in RRMM - Master Protocol
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2